NeuroOne Medical Technologies Corp [NMTC] stock is trading at $0.85, up 7.23%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NMTC shares have gain 11.24% over the last week, with a monthly amount glided 11.86%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
NeuroOne Medical Technologies Corp [NASDAQ: NMTC] stock has seen the most recent analyst activity on May 05, 2025, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $1.45. Previously, Craig Hallum downgraded its rating to Hold on March 29, 2022, and dropped its price target to $2.
NeuroOne Medical Technologies Corp [NMTC] stock has fluctuated between $0.40 and $1.39 over the past year. NeuroOne Medical Technologies Corp [NASDAQ: NMTC] shares were valued at $0.85 at the most recent close of the market.
Analyzing the NMTC fundamentals
NeuroOne Medical Technologies Corp [NASDAQ:NMTC] reported sales of 9.63M for the trailing twelve months, which represents a growth of 105.39%. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at -0.86%, Pretax Profit Margin comes in at -0.81%, and Net Profit Margin reading is -0.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -1.63 and Total Capital is -0.6. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8034 points at the first support level, and at 0.7567 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9234, and for the 2nd resistance point, it is at 0.9967.
Ratios To Look Out For
For context, NeuroOne Medical Technologies Corp’s Current Ratio is 7.13. Further, the Quick Ratio stands at 5.80, while the Cash Ratio is 5.64. Considering the valuation of this stock, the price to sales ratio is 4.41, the price to book ratio is 5.18.
Transactions by insiders
Recent insider trading involved Christianson Mark, Officer, that happened on Aug 20 ’25 when 30000.0 shares were purchased. Business Development Director, Christianson Mark completed a deal on Jun 04 ’25 to sell 10000.0 shares. Meanwhile, Business Development Director Christianson Mark sold 8967.0 shares on May 22 ’25.
